These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6783923)

  • 1. The new mixed agonist-antagonist analgesics, nalbuphine and butorphanol, vs. pentazocine: relapse and substitution in morphine-addict rats.
    Steinfels GF; Young GA; Khazan N
    NIDA Res Monogr; 1981 Feb; 34():138-44. PubMed ID: 6783923
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-administration of nalbuphine, butorphanol and pentazocine by morphine post-addict rats.
    Steinfels GF; Young GA; Khazan N
    Pharmacol Biochem Behav; 1982 Jan; 16(1):167-71. PubMed ID: 7199184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nalbuphine, pentazocine, and butorphanol interactions with tripelennamine in mice.
    Schmidt WK; Marynowski ME; Smith C
    NIDA Res Monogr; 1986; 67():145-6. PubMed ID: 3092060
    [No Abstract]   [Full Text] [Related]  

  • 4. Nalbuphine.
    Schmidt WK; Tam SW; Shotzberger GS; Smith DH; Clark R; Vernier VG
    Drug Alcohol Depend; 1985 Feb; 14(3-4):339-62. PubMed ID: 2986929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opiate mixed agonist-antagonist interactions with histamine antagonists vs. morphine.
    Hui FW; Sun CL; Hanig JP
    Neurobehav Toxicol Teratol; 1985; 7(5):443-7. PubMed ID: 4080063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of self-administration.
    Balster RL; Lukas SE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):249-61. PubMed ID: 3888576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution and primary dependence studies in animals.
    Woods JH; Gmerek DE
    Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enflurane sparing effect of morphine, butorphanol, and nalbuphine.
    Murphy MR; Hug CC
    Anesthesiology; 1982 Dec; 57(6):489-92. PubMed ID: 7149306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug discrimination in human postaddicts: agonist-antagonist opioids.
    Preston KL; Bigelow GE; Bickel WK; Liebson IA
    J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of nalbuphine hydrochloride.
    Miller RR
    Am J Hosp Pharm; 1980 Jul; 37(7):942-9. PubMed ID: 6994499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of nalbuphine and butorphanol treatment on cocaine and food self-administration by rhesus monkeys.
    Mello NK; Kamien JB; Lukas SE; Drieze J; Mendelson JH
    Neuropsychopharmacology; 1993 Jan; 8(1):45-55. PubMed ID: 8381011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of morphine, nalbuphine, and butorphanol on adrenergic function in canine saphenous veins.
    Muldoon S; Otto J; Freas W; Watson RL
    Anesth Analg; 1983 Jan; 62(1):21-8. PubMed ID: 6129820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Butorphanol and nalbuphine: a pharmacologic comparison.
    Pallasch TJ; Gill CJ
    Oral Surg Oral Med Oral Pathol; 1985 Jan; 59(1):15-20. PubMed ID: 2983281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of butorphanol, nalbuphine, and fentanyl on intrabiliary tract dynamics.
    McCammon RL; Stoelting RK; Madura JA
    Anesth Analg; 1984 Feb; 63(2):139-42. PubMed ID: 6691579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic.
    Pircio AW; Gylys JA; Cavanagh RL; Buyniski JP; Bierwagen ME
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):231-57. PubMed ID: 60089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
    Jones HE; Bigelow GE; Preston KL
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
    Preston KL; Bigelow GE
    J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of morphine, nalbuphine and pentazocine on gastric emptying of indigestible solids.
    Asai T
    Arzneimittelforschung; 1998 Aug; 48(8):802-5. PubMed ID: 9748706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate receptor pharmacology: mixed agonist/antagonist narcotics.
    Hameroff SR
    Contemp Anesth Pract; 1983; 7():27-43. PubMed ID: 6136392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.